Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective Hillel P. CohenMatthew TurnerGillian R. Woollett Current Opinion Open access 05 August 2023 Pages: 583 - 593
Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia Courtney D. ThornburgDana H. SimmonsAnnette von Drygalski Review Article Open access 25 July 2023 Pages: 595 - 606
Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria Bernardo Cavallazzi SeboldJunjie LiTianfang Wang Review Article Open access 10 June 2023 Pages: 607 - 623
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases Jasvinder A. Singh Review Article 23 June 2023 Pages: 625 - 635
Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments Wonju LeeSang Min LeeSang Taek Jung Review Article 24 July 2023 Pages: 637 - 648
Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management Alexander H. WilliamsChang-Guo Zhan Review Article 18 July 2023 Pages: 649 - 674
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy Francesco CiccimarraNicoletta LuxiGianluca Trifirò Original Research Article Open access 06 May 2023 Pages: 675 - 684
Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions Imke A. M. DittersHarmke A. van KootenHidde H. Huidekoper Original Research Article Open access 16 June 2023 Pages: 685 - 698
Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database Orhon PaulineMarion RobertCharles Khouri Original Research Article 06 June 2023 Pages: 699 - 707
In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart Akshay G. MishraRutuja B. DeshmaneArchana R. Krishnan Original Research Article 07 June 2023 Pages: 709 - 719
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese Adults Chen LiHaiyan LiuYi Fang Original Research Article 06 June 2023 Pages: 721 - 735